| Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin P Gazerani, NS Pedersen, C Staahl, AM Drewes, L Arendt-Nielsen PAIN® 141 (1-2), 60-69, 2009 | 195 | 2009 |
| The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization P Gazerani, C Staahl, AM Drewes, L Arendt-Nielsen Pain 122 (3), 315-325, 2006 | 186 | 2006 |
| Sex-related differences in pain BE Cairns, P Gazerani Maturitas 63 (4), 292-296, 2009 | 185 | 2009 |
| MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions HH Andersen, M Duroux, P Gazerani Neurobiology of disease 71, 159-168, 2014 | 180 | 2014 |
| Addressing potential impact of COVID-19 pandemic on physical and mental health of elite athletes AH Mehrsafar, P Gazerani, AM Zadeh, JCJ Sánchez Brain, behavior, and immunity 87, 147, 2020 | 179 | 2020 |
| A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences P Gazerani, OK Andersen, L Arendt-Nielsen Pain 118 (1-2), 155-163, 2005 | 160 | 2005 |
| Pressure pain thresholds assessed over temporalis, masseter, and frontalis muscles in healthy individuals, patients with tension-type headache, and those with migraine—A … S Andersen, MW Petersen, AS Svendsen, P Gazerani Pain 156 (8), 1409-1423, 2015 | 122 | 2015 |
| Migraine and diet P Gazerani Nutrients 12 (6), 1658, 2020 | 121 | 2020 |
| Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women P Gazerani, K Wang, BE Cairns, P Svensson, L Arendt-Nielsen Pain 124 (3), 338-348, 2006 | 120 | 2006 |
| Probiotics for Parkinson’s disease P Gazerani International journal of molecular sciences 20 (17), 4121, 2019 | 119 | 2019 |
| Determination of metformin in human plasma by high-performance liquid chromatography H Amini, A Ahmadiani, P Gazerani Journal of Chromatography B 824 (1-2), 319-322, 2005 | 99 | 2005 |
| Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine … P Gazerani, S Au, X Dong, U Kumar, L Arendt-Nielsen, BE Cairns PAIN® 151 (3), 606-616, 2010 | 91 | 2010 |
| Botulinum toxin type a as a therapeutic agent against headache and related disorders S Luvisetto, P Gazerani, C Cianchetti, F Pavone Toxins 7 (9), 3818-3844, 2015 | 86 | 2015 |
| The effects of mindfulness training on competition-induced anxiety and salivary stress markers in elite Wushu athletes: A pilot study AH Mehrsafar, J Strahler, P Gazerani, M Khabiri, JCJ Sánchez, ... Physiology & behavior 210, 112655, 2019 | 85 | 2019 |
| Serum microRNA signatures in migraineurs during attacks and in pain-free periods HH Andersen, M Duroux, P Gazerani Molecular neurobiology 53, 1494-1500, 2016 | 82 | 2016 |
| Botulinum toxin type A reduces histamine‐induced itch and vasomotor responses in human skin P Gazerani, NS Pedersen, AM Drewes, L Arendt‐Nielsen British Journal of Dermatology 161 (4), 737-745, 2009 | 77 | 2009 |
| A correlation between migraine, histamine and immunoglobulin E P Gazerani, Z Pourpak, A Ahmadiani, A Hemmati, A Kazemnejad Scandinavian journal of immunology 57 (3), 286-290, 2003 | 73 | 2003 |
| Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model F Dardmeh, H Alipour, P Gazerani, G van der Horst, E Brandsborg, ... PLoS One 12 (10), e0185964, 2017 | 69 | 2017 |
| Effect of local controlled heat on transdermal delivery of nicotine KK Petersen, ML Rousing, C Jensen, L Arendt-Nielsen, P Gazerani International journal of physiology, pathophysiology and pharmacology 3 (3), 236, 2011 | 66 | 2011 |
| The impact of ethnic differences in response to capsaicin-induced trigeminal sensitization P Gazerani, L Arendt-Nielsen Pain 117 (1-2), 223-229, 2005 | 65 | 2005 |
